FP
COV

Foundry Partners’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Foundry Partners’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-90,120
Closed -$9.22M – 295
2014
Q4 		$9.22M Buy
90,120
+13,045
+17% +$1.25M 0.76% 49
2014
Q3 		$6.67M Sell
77,075
-32,825
-30% -$2.91M 0.62% 68
2014
Q2 		$9.91M Sell
109,900
-5,650
-5% -$423K 0.92% 27
2014
Q1 		$8.51M Buy
115,550
+28,475
+33% +$1.99M 0.8% 39
2013
Q4 		$5.93M Buy
+87,075
New +$5.67M 0.53% 72

Foundry Partners's COV Position: Q1 2015 in Review

Foundry Partners sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 90,120 shares — an estimated $9.22M sold.

Foundry Partners first reported a position in COV in Q4 2013 and held it in 5 quarters. The position peaked at $9.91M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Foundry Partners reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Foundry Partners sold 90,120 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $9.22M.
  • Foundry Partners first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2013 and held it in 5 quarters.
  • Foundry Partners's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $9.91M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Foundry Partners's 13F filing for Q1 2015, filed 14 Apr 2015.